No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MBOT Microbot Medical
- 0.911
- -0.042-4.44%
Close May 8 16:00 ET
- 0.913
- +0.003+0.27%
Post 16:27 ET
13.11MMarket Cap-867P/E (TTM)
0.970High0.911Low53.37KVolume0.970Open0.953Pre Close49.70KTurnover0.38%Turnover RatioLossP/E (Static)14.40MShares4.37052wk High2.91P/B12.88MFloat Cap0.86052wk Low--Dividend TTM14.15MShs Float323999.370Historical High--Div YieldTTM6.25%Amplitude0.860Historical Low0.931Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Microbot Medical's LIBERTY System Success With Corewell Health
Microbot Medical Announces Positive Results From the First Phase of Its Collaboration With Corewell Health
The next step of the collaboration will explore potential future applications of the LIBERTY system, including its potential capabilities for remote endovascular proceduresBRAINTREE, Mass., April 29,
Microbot Medical Outlines Regulatory Goals and Investor Cautions
Microbot Medical Anticipates Receiving 510(K) Clearance From FDA In H1 2025, And CE MARK Approval In H2 2025
Microbot Medical Anticipates Receiving 510(K) Clearance From FDA In H1 2025, And CE MARK Approval In H2 2025
Microbot Medical Is Maintained at Buy by HC Wainwright & Co.
Microbot Medical Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. : The Microbot Medical (MBOT.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $8.00 to $7.00.
HC Wainwright & Co. : The Microbot Medical (MBOT.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $8.00 to $7.00.
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg